- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07749534
Quality of Life, Psychosocial Burden, and Structural-functional Status in Adults With Spinal Deformity. (ASD-QoL)
This study examines which factors influence quality of life in adults with a spinal deformity. It looks at imaging findings together with pain, daily functioning, psychosocial factors, and frailty to support more person-centred care.
A total of 320 adults will participate in three groups: conservative treatment, first corrective surgery, or reoperation. All care follows standard practice; no experimental treatments are added. Participants complete questionnaires, and routine FASD tests and existing EOS/X-ray images may be used.
Follow-up lasts up to 2 years, with scheduled assessments depending on whether treatment is surgical or conservative.
Study Overview
Status
Intervention / Treatment
Detailed Description
This study investigates which factors are associated with quality of life in adults with a spinal deformity. Among patients with a comparable spinal alignment, pain, daily functioning, and quality of life can vary greatly. Therefore, the study examines not only the structural abnormality on medical imaging, but also pain, limitations in daily functioning, anxiety and low mood, fear of movement, concern about falling, participation in daily life, and overall frailty. The results may contribute to a more person-centred assessment and treatment of adults with a spinal deformity.
A total of 320 adults with a spinal deformity will be included. The study compares three groups: patients treated conservatively, patients undergoing a first corrective surgery, and patients undergoing a reoperation. Treatment is entirely determined by the regular care team; the study does not add any experimental intervention. Participants complete questionnaires on quality of life, back symptoms, functioning, and psychosocial well-being. Where applicable, the Function Assessment Scale for Spinal Deformity (FASD) is administered, a functional movement test that is part of standard care. Available EOS or X-ray images from routine care are used; no additional images are taken solely for the study.
Follow-up lasts up to 2 years. For surgically treated participants, assessments may take place at surgery and around 6 weeks, 4 months, 1 year, and 2 years post-operatively. Conservatively treated participants are assessed at baseline and, where appropriate within routine care, around 1 and 2 years.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lieven Moke, prof. dr.
- Phone Number: 016338827
- Email: lieven.moke@uzleuven.be
Study Locations
-
-
-
Leuven, Belgium, 3200
- Recruiting
- UZ Leuven
-
Contact:
- Lieven prf. Moke, prf. dr
- Phone Number: 016338827
- Email: lieven.moke@uzleuven.be
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
- Age at inclusion 18 years or older.
- Diagnosed with Adult spinal deformity
Planned routine management through one of the following pathways:
- Conservative/non-operative management;
- Primary ASD surgery;
- Revision ASD surgery.
- Ability to complete the Dutch-language questionnaire package.
Exclusion Criteria:
- No valid informed consent.
- Missing baseline structural imaging required for endpoint determination. We allow images to be older than 2 years if no new radiographs are obtained, in accordance with the ALARA principle.
- Inability to complete the Dutch-language questionnaire package.
- Known cognitive impairment, severe psychiatric condition, or other condition that, in the Investigator's judgement, precludes valid informed consent or reliable completion of study assessments.
- Primary spinal condition other than adult spinal deformity that is expected to invalidate endpoint assessment, including acute traumatic, infectious, tumour-related, or inflammatory spinal pathology as the main reason for presentation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Fist corrective surgery
patients undergoing a first corrective surgery
|
patients undergoing a first corrective surgery or reoperation for ASD
|
|
Experimental: Reoperation
patients undergoing a reoperation
|
patients undergoing a reoperation
|
|
No Intervention: treated conservatively
patients who are treated conservatively
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cross-sectional associations in QoL between conservative, primary surgery, and revision surgery study groups.
Time Frame: within a period of 2 year
|
QoL is measured using the SRS-22r questionnaire during screening visit, at 6-weeks, 4 months, 1 year and 2 year.For Scoliosis Research Society 22 Revised (SRS-22r) questionaire a patient reported measure of health related quality of life in individuals with scoliosis.
PROM assessing five domains: Function/Activity, Pain, Self image/Appearance, Mental Health, Satisfaction with Management.
The mean score is located between 5 (Best) and 1 (Worst).
|
within a period of 2 year
|
|
Cross sectional associations in QoL between conservative, primary surgery, and revision surgery study groups.
Time Frame: Withing 2 years
|
QoL is measured using EQ-5D-5L questionnaire questionnaire during screening visit, at 6-weeks, 4 months, 1 year and 2 year The EuroQol 5 Dimension 5 Level(EQ-5D-5L) include 5-digit health profile: Mobility, Self Care, Usual Activities, Pain/Discomfort, Anxiety/Depression converting it to an index value using the country-specific value set (range -0.59 to 1.0).
EQ-5D-5L score expresses health status as a utility value ranging from <0 (worse than death) to 1 (full health).
Higher values indicate better overall health.
|
Withing 2 years
|
|
Cross sectional associations in QoL between conservative, primary surgery, and revision surgery study groups.
Time Frame: Withing 2 years
|
QoL is measured using VAS questionnaire during screening visit, at 6-weeks, 4 months, 1 year and 2 year The Visual Anlog Score (VAS) - ranges from 0 to 100, where 0 means "worst imaginable health" and 100 means "best imaginable health."
A higher VAS score reflects better self perceived health.
|
Withing 2 years
|
|
Cross sectional associations in QoL between conservative, primary surgery, and revision surgery study groups.
Time Frame: Withing 2 years
|
QoL in non-revision ASD patients, adjusted for structural deformity severity, demographic characteristics, treatment pathway, and frailty-related health status.
Structural covariates include Sagittal Vertical Axis(SVA), Pelvic tilt(PT), Pelvic incidence-lumbar lordosis mismatch (PI-LL) mismatch, and coronal Cobb angle.
Frailty-related health status will be measured using the mFI-5.
The modified 5-item frailty index (mFI-5) which assesses five clinical deficits: diabetes, hypertension, congestive heart failure, chronic obstructive pulmonary disease, and functional dependence.
Each deficit is scored as 0 (absent) or 1 (present).
The unit of measure is the total frailty score ranging from 0 to 5, where higher scores indicate greater frailty.
|
Withing 2 years
|
|
Cross-sectional associations in psychosocial burden between conservative, primary surgery, and revision surgery study groups.
Time Frame: within a period of 2 year
|
Measures include HADS during screening visit, at 6-weeks, 4 months, 1 year and 2 year.
Hospital Anxiety and Depression Scale (HADS) a validated 14 item self report questionnaire assessing symptoms of anxiety and depression.
Each item is scored on a 0-3 Likert scale, and the unit of measure is the subscale total score for Anxiety (HADS A, range 0-21) and Depression (HADS D, range 0-21).
Higher scores indicate more severe symptoms.
|
within a period of 2 year
|
|
Cross sectional associations in psychosocial burden between conservative, primary surgery, and revision surgery study groups.
Time Frame: Withing 2 years
|
Measures include FABQ-DV during screening visit, at 6-weeks, 4 months, 1 year and 2 year.
Fear Avoidance Beliefs Questionnaire - Dutch Version( FABQ-DV) validated self report instrument assessing fear avoidance beliefs related to physical activity and work.
The questionnaire contains items scored on a Likert scale from 0 to 6, where higher scores indicate stronger fear avoidance beliefs.
The unit of measure is the total score per subscale (Physical Activity and Work), each expressed as the sum of item scores, with higher totals reflecting greater fear avoidance.
|
Withing 2 years
|
|
Cross sectional associations in psychosocial burden between conservative, primary surgery, and revision surgery study groups.
Time Frame: Withing 2 years
|
Measures include FES-I during screening visit, at 6-weeks, 4 months, 1 year and 2 year.
Falls Efficacy Scale - International (FES-I) a validated self report questionnaire assessing fear of falling during everyday activities.
The instrument contains 16 items, each scored on a 4 point Likert scale (1-4).
The unit of measure is the total score ranging from 16 to 64, where higher scores indicate greater fear of falling.
|
Withing 2 years
|
|
Cross sectional associations in psychosocial burden between conservative, primary surgery, and revision surgery study groups.
Time Frame: Withing 2 years
|
Measures include IPA during screening visit, at 6-weeks, 4 months, 1 year and 2 year.
Impact on Participation and Autonomy Questionnaire (IPA) a validated self report instrument assessing perceived participation restrictions and autonomy in daily life.
The questionnaire contains multiple domains (e.g., Autonomy Indoors, Autonomy Outdoors, Social Life, Family Role, Work/Education), with items scored on a Likert scale from 0 to 4. The unit of measure is the domain score, expressed as the mean or sum of item scores, where higher scores indicate greater perceived limitations in participation and autonomy.
|
Withing 2 years
|
|
Cross-sectional associations in functional impairment between conservative, primary surgery, and revision surgery study groups.
Time Frame: within a period of 2 year
|
Measures include FASD.
Function Assessment scale for Spinal Deformity (FASD) contains 14 items across three subscales: spinal balance/mobility, stability limits/sensory integration, and ADL/gait.
Each is graded on an ordinal 3- or 4-point scale.
The maximum total score is 56; higher numbers represent better functional performance.
|
within a period of 2 year
|
|
Cross sectional associations in functional impairment between conservative, primary surgery, and revision surgery study groups.
Time Frame: Withing 2 years
|
Measures include ODI.
Oswestry Disability Index (ODI) summerise the points from all 10 completed sections like pain intensity, lifting, and walking (each scored from 0 (least disability) to 5 (severe disability).
Score is reported as a percentage from 0% to 100% that measures functional impairment from low back pain, divided into five standard ranges: minimal disability (0-20%), moderate disability (21-40%), severe disability (41-60%), crippled (61-80%), and bed-bound or exaggerating symptoms (81-100%)
|
Withing 2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cross-sectional differences between conservative, primary surgery, and revision surgery groups.
Time Frame: within a period of 2 year
|
Cross-sectional differences between conservative, primary surgery, and revision surgery groups in QoL, psychosocial burden, functional impairment, structural deformity severity, spine-specific symptom burden, and frailty-related health status.
Longitudinal within-patient changes across repeated routine-care follow-up timepoints in SRS-22r, EQ-5D-5L, HADS, FABQ-DV, FES-I, IPA, FASD, ODI, COMI, SVA, PT, PI-LL mismatch, coronal Cobb angle, and mFI-5.
The use of these scales is already described in the primary outcomes.
|
within a period of 2 year
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- S72384
- Research chair IORT (Other Grant/Funding Number: Medtronic)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.